Cargando…
Impact of COVID-19 related delays of botulinum toxin injections on the quality of life of patients with dystonia or spasticity
Autores principales: | Teuschl, Yvonne, Pinter, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498474/ http://dx.doi.org/10.1016/j.jns.2021.119914 |
Ejemplares similares
-
COVID-19-related delays of botulinum toxin injections have a negative impact on the quality of life of patients with dystonia and spasticity: a single-center ambulatory care study
por: Teuschl, Yvonne, et al.
Publicado: (2021) -
The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021) -
Botulinum Toxin-A for the Treatment of Neuropathic Pain after Decompressive Craniotomy in Stroke: Two Cases
por: Teuschl, Yvonne, et al.
Publicado: (2023) -
Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity
por: Roncoroni, Lorenzo Pietro, et al.
Publicado: (2020) -
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity
por: Dressler, Dirk, et al.
Publicado: (2021)